NFKB1 and cancer: Further, we showed that E2 is a more potent inhibitor of proliferation and migration in TNBC cells expressing a constitutively active form of p65, suggesting that p65 plays an important role in mediating the anti-cancer effects of ERβ and indicating that ERβ-targeted therapies may be most effective in tumors with high NFκB/p65 activity.